Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
A Type B meeting between the FDA and Plus Therapeutics offered clarity and direction for the next steps in development of ...
PsyPost on MSN
Blue-blocking glasses fail to alleviate mania
A new clinical trial conducted by researchers in Canada has found that wearing blue-blocking glasses did not significantly ...
Partnership expands access to clinically proven esophageal protection for atrial fibrillation ablation across federal ...
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving ...
Moving Biotech receives US FDA’s IND clearance for 4P004; strengthens its position as a leading innovator in disease-modifying osteoarthritis therapeutics: Lille, France Saturd ...
Transdermal berberine patches represent an emerging supplement format driven by consumer interest in convenience and non-pill delivery. While ingredient-level research on berberine and chromium exists ...
EatingWell on MSN
We Asked 4 Trainers the Best Exercise Combo to Lose Visceral Fat—Here’s What They Said
“It may sound underwhelming, but the science is clear: walking performed at a moderate pace, especially when done ...
Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results